Effect of modulation of the GPR39 zinc receptor on glutamatergic and gabaergic transmission in the context of antidepressant and anxiolytic activity.
2016/21/N/NZ7/03094
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 11 – announced on 2016-03-15
- Amount awarded
- 100 000 PLN
- Project start date
- 2017-03-08
- Project end date
- 2019-09-07
- Project duration
- 30 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Komputer typu laptop. Cost: 3 000 PLN
- Uniesiony labirynt krzyżowy. Cost: 7 000 PLN
Information in the final report
Publication in academic press/journals (1)
-
The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission
- Authors:
- Gabriela Starowicz; Dominika Siodłak; Gabriel Nowak; Katarzyna Mlyniec
- Academic press:
- Pharmacological Reports (year: 2023, volume: Online ahead of print, pages: Online ahead of print), Publisher: Springer
- Status:
- Published
- DOI:
- 10.1007/s43440-023-00478-0 – link to the publication